The apocalypse that wasn’t: AI was everywhere in 2024’s elections, but deepfakes and misinformation were only part of the picture
In 2024, AI significantly influenced elections globally, aiding communication and fundraising while generating concerns about misinformation, yet its harmful impact was less severe than anticipated.
It’s been the biggest year for elections in human history: 2024 is a “super-cycle” year in which 3.7 billion eligible voters in 72 countries had the chance to go the polls. These are also the first AI elections, where many feared that deepfakes and artificial intelligence-generated misinformation would overwhelm the democratic processes. As 2024 draws to a close, it’s instructive to take stock of how democracy did.
In a Pew survey of Americans from earlier this fall, nearly eight times as many respondents expected AI to be used for mostly bad purposes in the 2024 election as those who thought it would be used mostly for good. There are real concerns and risks in using AI in electoral politics, but it definitely has not been all bad.
The dreaded “death of truth” has not materialized – at least, not due to AI. And candidates are eagerly adopting AI in many places where it can be constructive, if used responsibly. But because this all happens inside a campaign, and largely in secret, the public often doesn’t see all the details.
Connecting with voters
One of the most impressive and beneficial uses of AI is language translation, and campaigns have started using it widely. Local governments in Japan and California and prominent politicians, including India Prime Minister Narenda Modi and New York City Mayor Eric Adams, used AI to translate meetings and speeches to their diverse constituents.
Even when politicians themselves aren’t speaking through AI, their constituents might be using it to listen to them. Google rolled out free translation services for an additional 110 languages this summer, available to billions of people in real time through their smartphones.
Other candidates used AI’s conversational capabilities to connect with voters. U.S. politicians Asa Hutchinson, Dean Phillips and Francis Suarez deployed chatbots of themselves in their presidential primary campaigns. The fringe candidate Jason Palmer beat Joe Biden in the American Samoan primary, at least partly thanks to using AI-generated emails, texts, audio and video. Pakistan’s former prime minister, Imran Khan, used an AI clone of his voice to deliver speeches from prison.
Perhaps the most effective use of this technology was in Japan, where an obscure and independent Tokyo gubernatorial candidate, Takahiro Anno, used an AI avatar to respond to 8,600 questions from voters and managed to come in fifth among a highly competitive field of 56 candidates. https://www.youtube.com/embed/N9GaiEgWjlE?wmode=transparent&start=0 ‘AI Steve’ was an AI persona who ran for office in the 2024 U.K. election.
Nuts and bolts
AIs have been used in political fundraising as well. Companies like Quiller and Tech for Campaigns market AIs to help draft fundraising emails. Other AI systems help candidates target particular donors with personalized messages. It’s notoriously difficult to measure the impact of these kinds of tools, and political consultants are cagey about what really works, but there’s clearly interest in continuing to use these technologies in campaign fundraising.
Polling has been highly mathematical for decades, and pollsters are constantly incorporating new technologies into their processes. Techniques range from using AI to distill voter sentiment from social networking platforms – something known as “social listening” – to creating synthetic voters that can answer tens of thousands of questions. Whether these AI applications will result in more accurate polls and strategic insights for campaigns remains to be seen, but there ispromisingresearch motivated by the ever-increasing challenge of reaching real humans with surveys.
In 2024, similar capabilities were almost certainly used in a variety of elections around the world. In the U.S., for example, a Georgia politician used AI to produce blog posts, campaign images and podcasts. Even standard productivity software suites like those from Adobe, Microsoft and Google now integrate AI features that are unavoidable – and perhaps very useful to campaigns. Other AI systems help advise candidates looking to run for higher office.
Fakes and counterfakes
And there was AI-created misinformation and propaganda, even though it was not as catastrophic as feared. Days before a Slovakian election in 2023, fake audio discussing election manipulation went viral. This kind of thing happened many times in 2024, but it’s unclear if any of it had any real effect.
In the U.S. presidential election, there was a lot of press after a robocall of a fake Joe Biden voice told New Hampshire voters not to vote in the Democratic primary, but that didn’t appear to make much of a difference in that vote. Similarly, AI-generated images from hurricane disaster areas didn’t seem to have much effect, and neither did a stream of AI-faked celebrity endorsements or viral deepfake images and videos misrepresenting candidates’ actions and seemingly designed to prey on their political weaknesses. https://www.youtube.com/embed/qs05muNU5dg?wmode=transparent&start=0 Russian intelligence services aimed to use AI to influence U.S. voters, but it’s not clear whether they had much success.
AI also played a role in protecting the information ecosystem. OpenAI used its own AI models to disrupt an Iranian foreign influence operation aimed at sowing division before the U.S. presidential election. While anyone can use AI tools today to generate convincing fake audio, images and text, and that capability is here to stay, tech platforms also use AI to automatically moderate content like hate speech and extremism. This is a positive use case, making content moderation more efficient and sparing humans from having to review the worst offenses, but there’s room for it to become more effective, more transparent and more equitable.
There is potential for AI models to be much more scalable and adaptable to more languages and countries than organizations of human moderators. But the implementations to date on platforms like Meta demonstrate that a lot more work needs to be done to make these systems fair and effective.
One thing that didn’t matter much in 2024 was corporate AI developers’ prohibitions on using their tools for politics. Despite market leader OpenAI’s emphasis on banning political uses and its use of AI to automatically reject a quarter-million requests to generate images of political candidates, the company’s enforcement has been ineffective and actual use is widespread.
The genie is loose
All of these trends – both good and bad – are likely to continue. As AI gets more powerful and capable, it is likely to infiltrate every aspect of politics. This will happen whether the AI’s performance is superhuman or suboptimal, whether it makes mistakes or not, and whether the balance of its use is positive or negative. All it takes is for one party, one campaign, one outside group, or even an individual to see an advantage in automation.
STM Daily News is a vibrant news blog dedicated to sharing the brighter side of human experiences. Emphasizing positive, uplifting stories, the site focuses on delivering inspiring, informative, and well-researched content. With a commitment to accurate, fair, and responsible journalism, STM Daily News aims to foster a community of readers passionate about positive change and engaged in meaningful conversations. Join the movement and explore stories that celebrate the positive impacts shaping our world.
Hollywood Legend Rob Reiner and Wife Found Dead; Son in Custody
Renowned filmmaker Rob Reiner and his wife, Michele Singer Reiner, were found dead in their Los Angeles home in a reported homicide. Police have arrested their son in connection with the case, and tributes are pouring in.
Director Rob Reiner participates in a discussion following a screening of the film LBJ at the LBJ Presidential Library in Austin, Texas on Saturday October 22, 2016 On Saturday evening October 22, 2016, the LBJ Presidential Library held a sneak peek of Rob Reiner’s new filmÊLBJ, starring Woody Harrelson as the 36th president. The film, which premiered at the Toronto International Film Festival in September, chronicles the life and times of Lyndon Johnson who would inherit the presidency at one of the most fraught moments in American history. Following the screening, director Rob Reiner, actor Woody Harrelson, and writer Joey Hartstone joined LBJ Library Director Mark Updegrove on stage for a conversation about the film. LBJ Library photo by Jay Godwin 10/22/2016
Hollywood Legend Rob Reiner and Wife Found Dead; Son in Custody
December 15, 2025
Renowned filmmaker and actor Rob Reiner, 78, and his wife Michele Singer Reiner, 68, were found dead in their Brentwood, Los Angeles home on Sunday, authorities say. Emergency responders were called to the residence Sunday afternoon, where both were discovered with fatal wounds consistent with a stabbing. Police are treating the case as a double homicide.
Los Angeles police arrested the couple’s 32-year-old son, Nick Reiner, in connection with the deaths. He is being held in custody as investigators continue to piece together the circumstances surrounding the incident.
2016 SAMHSA Voice Awards
Reiner was one of Hollywood’s most influential figures, known for his work as a director, producer and actor. His career spanned decades, from early television fame to directing beloved films that shaped American cinema.
Friends, colleagues and public figures have begun sharing tributes and reactions to the news as the investigation is ongoing.
More details will be updated as they become available.
FDA’s COVID-19 Vaccine Safety Claims Lack Solid Evidence—Why Overreaction Could Harm Public Health
COVID-19 vaccine safety: The FDA’s claims about COVID-19 vaccine deaths in children lack strong evidence and could restrict vaccine access. Learn why experts say VAERS reports aren’t proof, and how overreacting may harm public health and trust in vaccines.
The death of children due to an unsafe vaccine is a serious allegation. I am a pediatric cardiologist who has studied the link between COVID-19 vaccines and heart-related side effects such as myocarditis in children. To my knowledge, studies to date have shown such side effects are rare, and severe outcomes even more so. However, I am open to new evidence that could change my mind. But without sufficient justification and solid evidence, restricting access to an approved vaccine and changing well-established procedures for testing vaccines would carry serious consequences. These moves would limit access for patients, create roadblocks for companies and worsen distrust in vaccines and public health. In my view, it’s important for people reading about these FDA actions to understand how the evidence on a vaccine’s safety is generally assessed.
Determining cause of death
The FDA memo claims that the deaths of these children were directly related to receiving a COVID-19 immunization. From my perspective as a clinician, it is awful that any child should die from a routine vaccination. However, health professionals like me owe it to the public to uphold the highest possible standards in investigating why these deaths occurred. If the FDA has evidence demonstrating something that national health agencies worldwide have missed – widespread child deaths due to myocarditis caused by the COVID-19 vaccine – I don’t doubt that even the most pro-vaccine physician will listen. So far, however, no such evidence has been presented. While a death logged in VAERS is a starting point, on its own it is insufficient to conclude whether a vaccine caused the death or other medical causes were to blame. To demonstrate a causal link, FDA staff and physicians must align the VAERS report with physicians’ assessments of the patient, as well as data from other sources for monitoring vaccine safety. These include PRISM, which logs insurance claims data, and the Vaccine Safety Datalink, which tracks safety signals in electronic medical records. It’s known that most deaths logged only in VAERS of children who recently received vaccines have been incorrectly attributed to the vaccines – either by accident or in some cases on purpose by anti-vaccine activists.
Heart-related side effects of COVID-19 vaccines
In his Substack and Twitter accounts, Prasad has said that he believes the rate of severe cardiac side effects after COVID-19 vaccination is severely underestimated and that the vaccines should be restricted far more than they currently are. In a July 2025 presentation, Prasad quoted a risk of 27 cases per million of myocarditis in young men who received the COVID-19 vaccine. A 2024 review suggested that number was a bit lower – about 20 cases out of 1 million people. But that same study found that unvaccinated people had greater risk of heart problems after a COVID-19 infection than vaccinated people. In a different study, people who got myocarditis after a COVID-19 vaccination developed fewer complications than people who got myocarditis after a COVID-19 infection. Existing vaccine safety infrastructure in the U.S. successfully identifies dangers posed by vaccines – and did so during the COVID-19 pandemic. Today, most COVID-19 vaccines in the U.S. rely on mRNA technology. But as vaccines were first emerging during the COVID-19 pandemic, two pharmaceutical companies, Janssen and AstraZeneca, rolled out a vaccine that used a different technology, called a viral vector. This type of vaccine had a very rare but genuine safety problem that was detected.A report in VAERS is at most a first step to determining whether a vaccine caused harm. VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA formally recommended pausing their use, and they were later pulled from the market. Death due to myocarditis from COVID-19 vaccination is exceedingly rare. Demonstrating that it occurred requires proof that the person had myocarditis, evidence that no other reasonable cause of death was present, and the absence of any additional cause of myocarditis. These factors cannot be determined from VAERS data, however – and to date, the FDA has presented no other relevant data.
A problematic vision for future vaccine approvals
Currently, vaccines are tested both by seeing how well they prevent disease and by how well they generate antibodies, which are the molecules that help your body fight viruses and bacteria. Some vaccines, such as the COVID-19 vaccine and the influenza vaccine, need to be updated based on new strains. The FDA generally approves these updates based on how well the new versions generate antibodies. Since the previous generation of vaccines was already shown to prevent infection, if the new version can generate antibodies like the previous one, researchers assume its ability to prevent infection is comparable too. Later studies can then test how well the vaccines prevent severe disease and hospitalization. The FDA memo says this approach is insufficient and instead argues for replacing such studies with many more placebo-controlled trials – not just for COVID-19 vaccines but also for widely used influenza and pneumonia vaccines. That may seem reasonable theoretically. In practice, however, it is not realistic. Today’s influenza vaccines must be changed every season to reflect mutations to the virus. If the FDA were to require new placebo-controlled trials every year, the vaccine being tested would become obsolete by the time it is approved. This would be a massive waste of time and resources.Influenza vaccines must be updated for every flu season.Jacob Wackerhausen/iStock via Getty Images Plus Also, detecting vaccine-related myocarditis at the low rate at which it occurs would have required clinical trials many times larger than the ones that were done to approve COVID-19 mRNA vaccines. This would have cost at least millions of dollars more, and the delay in rolling out vaccines would have also cost lives. Placebo-controlled trials would require comparing people who receive the updated vaccine with people who remain unvaccinated. When an older version of the vaccine is already available, this means purposefully asking people to forgo that vaccine and risk infection for the sake of the trial, a practice that is widely considered unethical. Current scientific practice is that only a brand-new vaccine may be compared against placebo. While suspected vaccine deaths should absolutely be investigated, stopping a vaccine for insufficient reasons can lead to a significant drop in public confidence. That’s why it’s essential to thoroughly and transparently investigate any claims that a vaccine causes harm.
Tariffs 101: What they are, who pays them, and why they matter now
Learn what tariffs are, who pays them, and why they matter for the U.S. economy. Explore how import taxes impact prices, trade policy, and everyday consumers as the Supreme Court reviews Trump’s global tariffs.
Tariffs 101: What they are, who pays them, and why they matter now
Kent Jones, Babson College The U.S. Supreme Court is currently reviewing a case to determine whether President Donald Trump’s global tariffs are legal. Until recently, tariffs rarely made headlines. Yet today, they play a major role in U.S. economic policy, affecting the prices of everything from groceriesto autosto holiday gifts, as well as the outlook for unemployment, inflation and even recession. I’m an economist who studies trade policy, and I’ve found that many people have questions about tariffs. This primer explains what they are, what effects they have, and why governments impose them.
What are tariffs, and who pays them?
Tariffs are taxes on imports of goods, usually for purposes of protecting particular domestic industries from import competition. When an American business imports goods, U.S. Customs and Border Protection sends it a tariff bill that the company must pay before the merchandise can enter the country. Because tariffs raise costs for U.S. importers, those companies usually pass the expense on to their customers by raising prices. Sometimes, importers choose to absorb part of the tariff’s cost so consumers don’t switch to more affordable competing products. However, firms with low profit margins may risk going out of business if they do that for very long. In general, the longer tariffs are in place, the more likely companies are to pass the costs on to customers. Importers can also ask foreign suppliers to absorb some of the tariff cost by lowering their export price. But exporters don’t have an incentive to do that if they can sell to other countries at a higher price. Studies of Trump’s 2025 tariffs suggest that U.S. consumers and importers are already paying the price, with little evidence that foreign suppliers have borne any of the burden. After six months of the tariffs, importers are absorbing as much as 80% of the cost, which suggests that they believe the tariffs will be temporary. If the Supreme Court allows the Trump tariffs to continue, the burden on consumers will likely increase. While tariffs apply only to imports, they tend to indirectly boost the prices of domestically produced goods, too. That’s because tariffs reduce demand for imports, which in turn increases the demand for substitutes. This allows domestic producers to raise their prices as well.
A brief history of tariffs
The U.S. Constitution assigns all tariff- and tax-making power to Congress. Early in U.S. history, tariffs were used to finance the federal government. Especially after the Civil War, when U.S. manufacturing was growing rapidly, tariffs were used to shield U.S. industries from foreign competition. The introduction of the individual income tax in 1913 displaced tariffs as the main source of U.S. tax revenue. The last major U.S. tariff law was the Smoot-Hawley Tariff Act of 1930, which established an average tariff rate of 20% on all imports by 1933. Those tariffs sparked foreign retaliation and a global trade war during the Great Depression. After World War II, the U.S. led the formation of the General Agreement on Tariffs and Trade, or GATT, which promoted tariff reduction policies as the key to economic stability and growth. As a result, global average tariff rates dropped from around 40% in 1947 to 3.5% in 2024. The U.S. average tariff rate fell to 2.5% that year, while about 60% of all U.S. imports entered duty-free. While Congress is officially responsible for tariffs, it can delegate emergency tariff power to the president for quick action as long as constitutional boundaries are followed. The current Supreme Court case involves Trump’s use of the International Emergency Economic Powers Act, or IEEPA, to unilaterally change all U.S. general tariff rates and duration, country by country, by executive order. The controversy stems from the claim that Trump has overstepped his constitutional authority granted by that act, which does not mention tariffs or specifically authorize the president to impose them.
The pros and cons of tariffs
In my view, though, the bigger question is whether tariffs are good or bad policy. The disastrous experience of the tariff war during the Great Depression led to a broad global consensus favoring freer trade and lower tariffs. Research in economics and political science tends to back up this view, although tariffs have never disappeared as a policy tool, particularly for developing countries with limited sources of tax revenue and the desire to protect their fledgling industries from imports. Yet Trump has resurrected tariffs not only as a protectionist device, but also as a source of government revenue for the world’s largest economy. In fact, Trump insists that tariffs can replace individual income taxes, a view contested by most economists. Most of Trump’s tariffs have a protectionist purpose: to favor domestic industries by raising import prices and shifting demand to domestically produced goods. The aim is to increase domestic output and employment in tariff-protected industries, whose success is presumably more valuable to the economy than the open market allows. The success of this approach depends on labor, capital and long-term investment flowing into protected sectors in ways that improve their efficiency, growth and employment. Critics argue that tariffs come with trade-offs: Favoring one set of industries necessarily disfavors others, and it raises prices for consumers. Manipulating prices and demand results in market inefficiency, as the U.S. economy produces more goods that are less efficiently made and fewer that are more efficiently made. In addition, U.S. tariffs have already resulted in foreign retaliatory trade actions, damaging U.S. exporters. Trump’s tariffs also carry an uncertainty cost because he is constantly threatening, changing, canceling and reinstating them. Companies and financiers tend to invest in protected industries only if tariff levels are predictable. But Trump’s negotiating strategy has involved numerous reversals and new threats, making it difficult for investors to calculate the value of those commitments. One study estimates that such uncertainty has actually reduced U.S. investment by 4.4% in 2025. A major, if underappreciated, cost of Trump’s tariffs is that they have violated U.S. global trade agreements and GATT rules on nondiscrimination and tariff-binding. This has made the U.S. a less reliable trading partner. The U.S. had previously championed this system, which brought stability and cooperation to global trade relations. Now that the U.S. is conducting trade policy through unilateral tariff hikes and antagonistic rhetoric, its trading partners are already beginning to look for new, more stable and growing trade relationships. So what’s next? Trump has vowed to use other emergency tariff measures if the Supreme Court strikes down his IEEPA tariffs. So as long as Congress is unwilling to step in, it’s likely that an aggressive U.S. tariff regime will continue, regardless of the court’s judgment. That means public awareness of tariffs – and of who pays them and what they change – will remain crucial for understanding the direction of the U.S. economy. Kent Jones, Professor Emeritus, Economics, Babson College This article is republished from The Conversation under a Creative Commons license. Read the original article.
STM Daily News is a vibrant news blog dedicated to sharing the brighter side of human experiences. Emphasizing positive, uplifting stories, the site focuses on delivering inspiring, informative, and well-researched content. With a commitment to accurate, fair, and responsible journalism, STM Daily News aims to foster a community of readers passionate about positive change and engaged in meaningful conversations. Join the movement and explore stories that celebrate the positive impacts shaping our world.
